InspireMD, Inc. (NSPR)
NASDAQ: NSPR · Real-Time Price · USD
1.650
+0.010 (0.61%)
Mar 9, 2026, 3:07 PM EDT - Market open
InspireMD Revenue
InspireMD had revenue of $2.52M in the quarter ending September 30, 2025, with 39.39% growth. This brings the company's revenue in the last twelve months to $7.78M, up 14.04% year-over-year. In the year 2024, InspireMD had annual revenue of $7.01M with 12.96% growth.
Revenue (ttm)
$7.78M
Revenue Growth
+14.04%
P/S Ratio
8.93
Revenue / Employee
$117,864
Employees
66
Market Cap
69.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7.01M | 804.00K | 12.96% |
| Dec 31, 2023 | 6.21M | 1.03M | 20.00% |
| Dec 31, 2022 | 5.17M | 676.00K | 15.04% |
| Dec 31, 2021 | 4.50M | 2.01M | 80.89% |
| Dec 31, 2020 | 2.49M | -1.24M | -33.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Accuray | 436.97M |
| Treace Medical Concepts | 212.69M |
| Xtant Medical Holdings | 133.08M |
| Outset Medical | 119.48M |
| Pulmonx | 90.50M |
| MaxCyte | 34.42M |
| electroCore | 29.84M |
| Sensus Healthcare | 27.48M |
NSPR News
- 6 hours ago - InspireMD to Announce Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - InspireMD Announces Publication of the C-GUARDIANS Pivotal Trial Manuscript in the Journal of the American College of Cardiology (JACC) - GlobeNewsWire
- 3 months ago - Landmark CREST-2 Study Published in the New England Journal of Medicine Highlights the Benefits of Carotid Artery Stenting - GlobeNewsWire
- 3 months ago - InspireMD to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference - GlobeNewsWire
- 4 months ago - InspireMD, Inc. (NSPR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 months ago - InspireMD Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 4 months ago - InspireMD Names Peter A. Soukas, M.D. - GlobeNewsWire